Fundz

Treace Medical Concepts To Acquire Technology Enabling Patient Specific Instrumentation For Foot And Ankle Surgeries

PUBLIC · TMCIJun 01, 2023

Acquiring Company

Treace

Acquired Company

Technology

Ponte VedraSaint CloudManufacturingBiotechnologyHealthcareHealth CareMedicalMedical Device

Description

Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it has signed an asset purchase agreement to acquire certain assets of MIOS Marketing, LLC d/b/a RedPoint Medical3D (“RPM-3D”), a medical technology company offering pre-operative planning and patient-specific guides designed to deliver accurate surgical correction of deformities customized to the patient’s unique foot anatomy, for a purchase price of $20 million in an upfront cash payment, with up to $10 million in potential milestone payments.

Other recent acquisitions in Healthcare and Medical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Treace, and when

When Treace changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Treace raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Treace, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Treace. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Treace

Location

Ponte Vedra, Florida, United States

About

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion and helping patients get back to their active lifestyles. Treace Medical has expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible surgical correction of the midfoot to provide further support to hallux valgus patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Treace makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Guy
Likely contact at this company
••••••••@••••••••

See Guy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Treace's next move

Learn about Strategic plan

Frequently asked

Who acquired Technology?

Technology was acquired by Treace, based in Ponte Vedra. The deal was reported on June 1, 2023. Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Treace is publicly traded (TMCI) and operates in Manufacturing.

When did Treace acquire Technology?

Treace's acquisition of Technology was reported on June 1, 2023. Treace Medical Concepts, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Technology do?

This domain may be for sale! It is privately held, and is based in Saint Cloud.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.